Trial Profile
Phase II study of bortezomib maintenance therapy for multiple myeloma patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2019
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms BOMB-after
- 25 Apr 2019 Status changed from recruiting to completed.
- 03 Jul 2014 New trial record